ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0026

Mapping Cellular Landscape of Esophageal Epithelium in Systemic Sclerosis Using Single-cell Transcriptomics

Matthew Dapas1, Hadijat Makinde2, Tyler Therron2, Margarette Clevenger2, Cenfu Wei2, Mary Karns3, Kathleen Aren3, Dustin Carlson2, Alexandra Soriano1, Lutfiyya Muhammad4, John Pandolfino5, Harris Perlman2, Deborah Winter6 and Marie-Pier Tetreault2, 1Northwestern University FSM Division of Rheumatology, Chicago, IL, 2Northwestern University, Chicago, IL, 3Northwestern University Division of Rheumatology, Chicago, IL, 4Northwestern University Feinberg School of Medicine, Chicago, IL, 5Northwestern University, Feinberg School of Medicine, Wilmette, IL, 6Northwestern University, Skokie, IL

Meeting: ACR Convergence 2023

Keywords: genomics, Scleroderma

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: (0013–0039.5) Genetics, Genomics & Proteomics Poster

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Esophageal involvement is one of the strongest predictors of early mortality in individuals with systemic sclerosis (SSc). Individuals with SSc and esophageal involvement typically suffer from chronic acid reflux and dysphagia due to loss of esophageal motility. However, the pathogenesis of esophageal dysmotility in SSc is still poorly understood.

Recently, studies have demonstrated that esophageal epithelial cells (EECs) in the mucosa may play a more central role in the pathogenesis of SSc esophageal dysmotility than previously thought. Most studies implicating EECs, however, have been performed in mice or in vitro, and molecular analyses in humans have so far been limited to bulk tissues using microarrays with inadequate controls. In this study, we performed a thorough transcriptomic investigation of the SSc esophageal epithelium in humans using single-cell RNA sequencing (scRNA-seq) to determine whether distinct molecular and cellular changes in EECs contribute to impaired motility of the esophageal wall in SSc.

Methods: We performed scRNA-seq of paired proximal and distal esophageal mucosa biopsies from 10 individuals with SSc and 6 healthy controls (HCs). We also evaluated samples from 4 individuals with gastroesophageal reflux disease (GERD) to distinguish primary SSc effects from secondary reflux effects. We further assessed esophageal motility (normal, weak, absent) in individuals with SSc using functional lumen imaging probe panometry and high-resolution manometry. Cells were encapsulated using the 10X Genomics Chromium platform and sequenced on the Illumina Novaseq 6000. Reads were aligned and quantified using Cell Ranger v6.1.2 and cell-specific gene expression was analyzed using Seurat v4.3.0.

Results: ScRNA-seq generated 12.4 billion reads from 434,582 cells across 40 sequenced samples. Following quality control, we annotated 230,720 EECs according to their differentiation state (basal, suprabasal, superficial). Overall proportions of basal, suprabasal, and replicating EECs were similar across conditions, but SSc and GERD samples had significantly fewer terminally differentiated, superficial cells than HCs. Differential gene expression analyses revealed dysregulated gene sets dependent on condition, biopsy region, and EEC layer. A surge of gene dysregulation in the transition from suprabasal to superficial states was observed in both SSc and GERD. We then modeled EEC differentiation as a continuous metric based on cumulative average expression of layer-specific markers and identified genes with condition-dependent expression trends as a function of EEC differentiation, highlighting genes uniquely dysregulated in SSc, including those correlated with esophageal dysmotility.

Conclusion: Esophageal dysmotility in SSc is associated with cellular and molecular changes in EECs distinct from secondary reflux effects. This work serves as an atlas for the human esophageal epithelium in SSc to direct future efforts to identify actionable targets for treatment.


Disclosures: M. Dapas: None; H. Makinde: None; T. Therron: None; M. Clevenger: None; C. Wei: None; M. Karns: None; K. Aren: None; D. Carlson: Medtronic, 2, 6, 12, license agreement; A. Soriano: None; L. Muhammad: None; J. Pandolfino: Medtronic, 2, 6; H. Perlman: None; D. Winter: Pfizer, 2; M. Tetreault: None.

To cite this abstract in AMA style:

Dapas M, Makinde H, Therron T, Clevenger M, Wei C, Karns M, Aren K, Carlson D, Soriano A, Muhammad L, Pandolfino J, Perlman H, Winter D, Tetreault M. Mapping Cellular Landscape of Esophageal Epithelium in Systemic Sclerosis Using Single-cell Transcriptomics [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/mapping-cellular-landscape-of-esophageal-epithelium-in-systemic-sclerosis-using-single-cell-transcriptomics/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/mapping-cellular-landscape-of-esophageal-epithelium-in-systemic-sclerosis-using-single-cell-transcriptomics/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology